Blocking Transmission of Viral Infections

Currently, interventions surrounding known virus infections focus on treatment: to accelerate viral clearance and to reduce symptoms

Ness Therapeutics aspires to transform the respiratory virus infection drug market from “treatment to cure” to “protection from infection” via prophylactic application for known and newly emerging viruses.

OUR VISION

1. Transform the respiratory virus infection drug market from ‘treatment to cure’ to ‘protection’ via prophylactic intervention for known and newly emerging, unknown viruses

2. Disrupt and move beyond more traditional approaches of vaccines and pathogen targeted therapeutics

3. Learn from our innate immune system

4. Establish a virus agnostic strategy

5. Block transmission from infected individuals

6. Utilize a group of proteins made and released by our body’s host cells in response to the presence of all viruses